Patent ID: 7880009

Claim:
A compound represented by Formula (I) or a pharmacologically acceptable salt thereof: wherein Ar 1 represents an imidazolyl group which may be substituted with 1 to 3 substituents selected from Substituent Group Al shown below; Ar 2 represents a phenyl group which may be substituted with 1 to 3 substituents selected from Substituent Group A2 shown below; and R 1 and R 2 , together with —X 1 —CO—N—, form: a cyclic group represented by Formula (VI): wherein —Z 3 —Z 4 —Z 5 — represents —CH 2 —CH 2 —CH 2 —; and R 1 is a C1-6 alkyl substituted with a phenyl group which may have 1 to 3 substituents selected from Substituent Group A4 shown below; and R 7 represents a hydrogen or a C1-6 alkyl group; Substituent Group A1: (1) a hydrogen atom, (2) a halogen atom, and (3) a C1-6 alkyl group (wherein the C1-6 alkyl group may be substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a hydroxyl group, a cyano group, a C1-6 alkoxy group, a C3-8 cycloalkyl group and a C1-6 alkylcarbonyl group); Substituent Group A2: (1) a hydrogen atom, (2) a halogen atom, (3) a hydroxyl group, (4) a cyano group, (5) a C1-6 alkoxy group (wherein the C1-6 alkoxy group may be substituted with 1 to 3 substituents selected from the group consisting of a halogen atom, a cyano group, a C1-6 alkoxy group, a C2-6 alkenyl group, a C2-6 alkynyl group and a C3-8 cycloalkyl group), (6) alkyl, (7) trifluoromethane, (8) phenyl, (9) nitro and (10) amino; Substituent Group A4: (1) a hydrogen atom, (2) a halogen atom, (3) a hydroxyl group, (4) a cyano group, (5) a nitro group, and (6) a C3-8 cycloalkyl group.